Stock Analysis: Innoviva

Company: Innoviva Incorporated

Bloomberg ticker: INVA US

Market cap: US$1,609m

Background: Innoviva Incorporated is a diversified healthcare asset management company headquartered in the United States that operates globally. The business manages a lucrative pharmaceutical royalty portfolio and sells specialty therapeutics. It is known for critical care products like Giapreza, Xerava, and Breo Ellipta.

World Class Benchmarking of Innoviva

• Profitable Growth rank of 1 was up compared to the prior period’s 8th rank

• This is World Class performance compared to 310 medium Health Care companies worldwide

• Profitability rank of 1 was the same as its Growth rank of 1

• Profitability rank of 1 was up compared to the prior period’s 7th rank

• This is World Class performance compared to peers

• Growth rank of 1 was up compared to the prior period’s 10th rank

• This is World Class performance compared to peers